تقرير
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.
العنوان: | Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial. |
---|---|
المؤلفون: | Fujiki, Shinya, Iijima, Kenichi, Nakagawa, Yoshihisa, Takahashi, Kazuyoshi, Okabe, Masaaki, Kusano, Kengo, Owada, Shingen, Kondo, Yusuke, Tsujita, Kenichi, Shimizu, Wataru, Tomita, Hirofumi, Watanabe, Masaya, Shoda, Morio, Watanabe, Masafumi, Tokano, Takashi, Murohara, Toyoaki, Kaneshiro, Takashi, Kato, Takeshi, Hayashi, Hidemori, Maemura, Koji, Niwano, Shinichi, Umemoto, Tomio, Yoshida, Hisako, Ota, Keiko, Tanaka, Takahiro, Kitamura, Nobutaka, Node, Koichi, Minamino, Tohru |
المصدر: | Cardiovasc Diabetol ; ISSN:1475-2840 ; Volume:23 ; Issue:1 |
بيانات النشر: | BioMed Central |
سنة النشر: | 2024 |
المجموعة: | PubMed Central (PMC) |
مصطلحات موضوعية: | Empagliflozin, Sodium-glucose cotransporter 2, Type 2 diabetes, Ventricular arrhythmia |
الوصف: | Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure and cardiovascular death with type 2 diabetes; however, their effect on arrhythmias is unclear. The purpose of this study was to investigate the effects of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes. |
نوع الوثيقة: | report article in journal/newspaper |
اللغة: | English |
العلاقة: | https://doi.org/10.1186/s12933-024-02309-9Test; https://pubmed.ncbi.nlm.nih.gov/38943159Test |
DOI: | 10.1186/s12933-024-02309-9 |
الإتاحة: | https://doi.org/10.1186/s12933-024-02309-9Test https://pubmed.ncbi.nlm.nih.gov/38943159Test |
حقوق: | © 2024. The Author(s). |
رقم الانضمام: | edsbas.39225AB0 |
قاعدة البيانات: | BASE |
DOI: | 10.1186/s12933-024-02309-9 |
---|